These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12106524)

  • 21. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users.
    Arnsten JH; Li X; Mizuno Y; Knowlton AR; Gourevitch MN; Handley K; Knight KR; Metsch LR;
    J Acquir Immune Defic Syndr; 2007 Nov; 46 Suppl 2():S64-71. PubMed ID: 18089986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of demographic and psychosocial factors on adherence to antiretroviral treatment].
    Ruiz-Pérez I; Olry de Labry-Lima A; Prada-Pardal JL; Rodríguez-Baño J; Causse-Prados M; López-Ruz MA; Martín-Rico P; del Arco-Jiménez A; Pasquau-Liaño J; de la Torre-Lima J; López-Gómez M; Muñoz-Roca N; Marcos-Herrero M; Muñoz I; Morales-Rojas D
    Enferm Infecc Microbiol Clin; 2006; 24(6):373-8. PubMed ID: 16792939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia.
    Chan PY; Joseph MA; Des Jarlais DC; Uusküla A
    Int J STD AIDS; 2018 Jan; 29(1):13-22. PubMed ID: 28618981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
    Grossberg R; Zhang Y; Gross R
    J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.
    Watson DC; Farley JJ
    Pediatr Infect Dis J; 1999 Aug; 18(8):682-9. PubMed ID: 10462336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda.
    Nakiwogga-Muwanga A; Katabira E; Kiragga A; Kambugu A; Nakibuuka-Lubwama E; Manabe YC; Alamo ST; Colebunders R
    Int J STD AIDS; 2014 Feb; 25(2):105-12. PubMed ID: 23970633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs.
    Lee WK; Milloy MJ; Walsh J; Nguyen P; Wood E; Kerr T
    Health Psychol; 2016 Mar; 35(3):290-7. PubMed ID: 26690643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens.
    Duong M; Piroth L; Grappin M; Forte F; Peytavin G; Buisson M; Chavanet P; Portier H
    HIV Clin Trials; 2001; 2(2):128-35. PubMed ID: 11590521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
    Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
    Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients.
    Casado JL; Sabido R; Perez-Elías MJ; Antela A; Oliva J; Dronda F; Mejía B; Fortún J
    Antivir Ther; 1999; 4(3):157-61. PubMed ID: 12731755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.
    Small W; Milloy MJ; McNeil R; Maher L; Kerr T
    AIDS Res Ther; 2016; 13():26. PubMed ID: 27462360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.